| − | *EP 3056199 A1 (US20160235696), Modification of the ph and other physical properties of oxaloacetic acid to allow for enhanced stability, 2015. Erfinder: Alan B. Cash <ref>https://www.google.ch/patents/EP3056199A1</ref> | + | *EP 3056199 A1 (US20160235696), Modification of the ph and other physical properties of oxaloacetic acid to allow for enhanced stability, 2015. Erfinder: Alan B. Cash <ref>https://www.google.ch/patents/EP3056199A1</ref> Zitat: |
| | + | :''..Oxaloacetic Acid has been shown to be a commercial nutritional supplement and medical food, selling around the world as "benaGene", "CRONaxal" and other labels licensed from Terra Biological LLC. It is currently in clinical trial for a drug for mitochondrial disease, Parkinson's disease, Alzheimer's disease and Cancer. Initially this compound was not used as a nutritional supplement, medical food or drug due to very serious stability problems..'' |